Table 2 Baseline characteristics
| Â | Experiments | Reliability | |
|---|---|---|---|
| Â | Controls | Controls | PFP patients |
Participants, n | 10 | 15 | 5 |
Female, n (%) | 6 (60.0) | 10 (66.7) | 4 (80.0) |
Age (yrs) | 21.7 (2.7) | 21.0 (2.6) | 22.2 (3.8) |
BMI (kg/m2) | 22.2 (2.1) | 22.0 (2.7) | 23.8 (3.1) |
Bilateral PFP, n (%) | n/a | n/a | 4 (80.0) |
Symptom duration (mos) | n/a | n/a | 47 (35.9) |
VAS-W (0–10) | n/a | n/a | 5 (1.1) |
Smoking, n (%) | 0 (0.0) | 0 (0.0) | 2 (40.0) |
Blood pressure (mmHg) | |||
 Systolic | 120.8 (11.1) | 120.7 (9.1) | 124.1 (8.0) |
 Diastolic | 80.7 (9.3) | 80.6 (8.6) | 80.7 (10.3) |
Sport participation (hrs/wk) | 7.5 (8.4) | 6.9 (8.4) | 4.4 (1.5) |
Tegner (0–10) | 6.5 (1.0) | 6.4 (0.9) | 6.2 (1.8) |
AKPS (0–100) | 98.4 (2.5) | 98.3 (2.1) *** | 87.2 (3.8) *** |
Patella (mm) | |||
 Width | 51.4 (3.1) | 51.2 (3.2) | 50.1 (3.2) |
 Skinfold | 7.0 (1.2) | 7.1 (1.8) | 7.7 (1.5) |